Cargando…

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases

The aim of the study was to clarify the effect of long-term anti-TNF therapy on T cell function in patients with rheumatologic immune-mediated inflammatory diseases (IMID). The production of IFNγ by T cells was evaluated at baseline and after 1, 2, 4, and 8 years of anti-TNF agents by means of a Qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sauzullo, Ilaria, Scrivo, Rossana, Sessa, Paola, Mengoni, Fabio, Vullo, Vincenzo, Valesini, Guido, Mastroianni, Claudio Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959893/ https://www.ncbi.nlm.nih.gov/pubmed/29777119 http://dx.doi.org/10.1038/s41598-018-26097-x

Ejemplares similares

Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
por: Scrivo, Rossana, et al.
Publicado: (2013)

Multifunctional Analysis of CD4(+) T-Cell Response as Immune-Based Model for Tuberculosis Detection
por: Lichtner, Miriam, et al.
Publicado: (2015)

In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response
por: Sauzullo, Ilaria, et al.
Publicado: (2009)

Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study
por: Rodio, Donatella Maria, et al.
Publicado: (2016)

Severe and Persistent Depletion of Circulating Plasmacytoid Dendritic Cells in Patients with 2009 Pandemic H1N1 Infection
por: Lichtner, Miriam, et al.
Publicado: (2011)

Anti-therapeutic antibodies and their clinical impact in patients treated with the TNF antagonist adalimumab
por: Cludts, Isabelle, et al.
Publicado: (2017)

Application of a Stochastic Modeling to Assess the Evolution of Tuberculous and Non-Tuberculous Mycobacterial Infection in Patients Treated with Tumor Necrosis Factor Inhibitors
por: Agliari, Elena, et al.
Publicado: (2013)

(1)H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis
por: Priori, Roberta, et al.
Publicado: (2015)

In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection
por: Gramegna, Pasqua, et al.
Publicado: (2011)

Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies
por: Scrivo, Rossana, et al.
Publicado: (2019)

CD8(+) T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis
por: Citro, Alessandra, et al.
Publicado: (2015)

Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors
por: Latronico, Tiziana, et al.
Publicado: (2016)

Comparison of the effects of air-powder abrasion, chemical decontamination, or their combination in open-flap surface decontamination of implants failed for peri-implantitis: an ex vivo study
por: Pranno, Nicola, et al.
Publicado: (2020)

Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
por: Gomez-Reino, Juan J, et al.
Publicado: (2006)

Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
por: Di Sanzo, Lorenzo, et al.
Publicado: (2022)

Defective production of interferon-γ and tumour necrosis factor-α by AIDS mononuclear cells after in vitro exposure to Rhodococcus equi
por: Delia, S., et al.
Publicado: (1995)

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections
por: Di Franco, Manuela, et al.
Publicado: (2017)

Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage
por: Conti, Fabrizio, et al.
Publicado: (2012)

Effective use of TNF antagonists
por: Yocum, David
Publicado: (2004)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Immunological diagnosis as an adjunctive tool for an early diagnosis of tuberculous meningitis of an immune competent child in a low tuberculosis endemic country: a case report
por: Vita, Serena, et al.
Publicado: (2017)

The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus
por: Scrivo, Rossana, et al.
Publicado: (2017)

Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
por: Mascia, Claudia, et al.
Publicado: (2017)

Interleukin-13 (IL-13)in autoimmune rheumatic diseases: relationship with autoantibody profile
por: Rinaldi, T, et al.
Publicado: (2001)

The Comparative Safety and Effectiveness of TNF-alpha Antagonists
por: Solomon, Daniel H.
Publicado: (2007)

Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
por: Zuccalà, Paola, et al.
Publicado: (2022)

Effects of anti-TNF therapy on ophtalmological complications in children with rheumatic diseases
por: Frkovic, Marijan, et al.
Publicado: (2014)

Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature
por: Ceccarelli, Giancarlo, et al.
Publicado: (2011)

In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter Baumannii
por: Oliva, Alessandra, et al.
Publicado: (2019)

TNF-alpha antagonists for treatment of juvenile ankylosing spondylitis
por: Orbán, I, et al.
Publicado: (2011)

Treating psoriatic arthritis: how effective are TNF antagonists?
por: Gottlieb, Alice B, et al.
Publicado: (2004)

Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
por: Brymer, Kyle J., et al.
Publicado: (2019)

Role of Tocilizumab in Down Regulating sCD163 Plasmatic Levels in a Cohort of COVID-19 Patients
por: Marocco, Raffaella, et al.
Publicado: (2022)

Relapsing and disseminated VZV infection associated with post-zoster neuralgia in an HIV-infected patient
por: Falciano, Mario, et al.
Publicado: (2000)

The Latent Period Before the Onset of Acute Rheumatic Fever
por: Rammelkamp, Charles H., et al.
Publicado: (1961)

Yeast as a Heterologous Model System to Uncover Type III Effector Function
por: Popa, Crina, et al.
Publicado: (2016)

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus
por: Zingaropoli, Maria A., et al.
Publicado: (2018)

Factors for starting biosimilar TNF inhibitors in patients with rheumatic diseases in the real world
por: Sung, Yoon-Kyoung, et al.
Publicado: (2020)

Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin
por: D'Abramo, Alessandra, et al.
Publicado: (2013)

Does route of administration affect the outcome of TNF antagonist therapy?
por: Schwartzman, Sergio, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_m46hmojpvtj89tmdm6iogqrquj